Neuroscience

 

21 Results were found on Technologies

10-2013-549

Novel specific disease-modifying PERK activator for Huntington’s disease

There is no efficient therapy at present for Huntington’s disease (HD) nor for any other neurodegenerative disease, including Alzheimer’s and Parkinson’s diseases. No disease-modifying approaches exist. Gene therapy-based clinical trials have... Read More >